Partial Seizures Clinical Trial
Official title:
A Randomized, Double-Blind, Parallel-Group Multi-Center Comparative Flexible-Dose Study Of Pregabalin Versus Levetiracetam As Adjunctive Therapy To Reduce Seizure Frequency In Subjects With Partial Seizures
This study will compare pregabalin and levetiracetam in patients with partial seizures. It will also evaluate the safety and tolerability of pregabalin and levetiracetam in these patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01954121 -
Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures
|
Phase 3 | |
| Completed |
NCT01630057 -
Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug
|
Phase 4 | |
| Completed |
NCT00327717 -
Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures
|
Phase 3 | |
| Completed |
NCT00141258 -
Pregabalin Epilepsy Add-On Trial
|
Phase 3 | |
| Completed |
NCT03340064 -
A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
|
Phase 3 | |
| Terminated |
NCT00407797 -
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
|
Phase 4 | |
| Completed |
NCT01136954 -
A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)
|
Phase 3 | |
| Completed |
NCT04257604 -
A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
|
||
| Completed |
NCT01392768 -
Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization
|
Phase 3 | |
| Completed |
NCT01063764 -
An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
|
Phase 3 | |
| Completed |
NCT00102713 -
A Study for Treatment of Partial Seizures in Children
|
Phase 3 | |
| Completed |
NCT01262677 -
Once-A-Day Pregabalin For Partial Seizures
|
Phase 3 |